876589-20-7 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
Explanation
The compound is derived from 1-azetidinecarboxylic acid by replacing the hydroxyl group (-OH) with an ester group.
Explanation
The chloromethyl group (-CH2Cl) is a functional group that is attached to the third carbon atom of the azetidine ring.
Explanation
The ester group is derived from a 1,1-dimethylethyl alcohol (tert-Pentanol) and is attached to the carboxylic acid group (-COOH) of the azetidinecarboxylic acid.
Explanation
The compound serves as a building block or intermediate in the synthesis of other pharmaceutical compounds.
Explanation
The specific arrangement of atoms and functional groups in the molecule provides unique reactivity, making it a valuable compound for the development of new drugs and pharmaceuticals.
Chemical structure
Ester derivative of 1-azetidinecarboxylic acid
Chloromethyl group
Attached to the third position of the azetidinecarboxylic acid core
1,1-Dimethylethyl ester group
Attached to the carboxylic acid functional group
Pharmaceutical intermediate
Used in the synthesis of various compounds
Unique structure and reactivity
Potential uses in medicinal chemistry and drug development
Check Digit Verification of cas no
The CAS Registry Mumber 876589-20-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,5,8 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 876589-20:
(8*8)+(7*7)+(6*6)+(5*5)+(4*8)+(3*9)+(2*2)+(1*0)=237
237 % 10 = 7
So 876589-20-7 is a valid CAS Registry Number.
876589-20-7Relevant academic research and scientific papers
Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents
Miller, John F.,Turner, Elizabeth M.,Gudmundsson, Kristjan S.,Jenkinson, Stephen,Spaltenstein, Andrew,Thomson, Michael,Wheelan, Pat
experimental part, p. 2125 - 2128 (2010/06/13)
The lead optimization of a series of N-substituted benzimidazole CXCR4 antagonists is described. Side chain modifications and stereochemical optimization led to substantial improvements in potency and protein shift to afford compounds with low nanomolar a
CHEMICAL COMPOUNDS
-
Page/Page column 69, (2010/10/20)
The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.
